about
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats.A microarray whole-genome gene expression dataset in a rat model of inflammatory corneal angiogenesis.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mediators of neovascularization and the hypoxic cornea.
@en
Mediators of neovascularization and the hypoxic cornea.
@nl
type
label
Mediators of neovascularization and the hypoxic cornea.
@en
Mediators of neovascularization and the hypoxic cornea.
@nl
prefLabel
Mediators of neovascularization and the hypoxic cornea.
@en
Mediators of neovascularization and the hypoxic cornea.
@nl
P2093
P2860
P1433
P1476
Mediators of neovascularization and the hypoxic cornea.
@en
P2093
Aidin Safvati
Mark Willcox
Nerida Cole
P2860
P304
P356
10.1080/02713680902919557
P577
2009-06-01T00:00:00Z